Oclacitinib Maleate
CAS: 1640292-55-2
Ref. 3D-QQC29255
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Oclacitinib Maleate
Description:
Oclacitinib Maleate is an orally-bioavailable small molecule drug candidate that inhibits the activity of the protein tyrosine kinase, which is a key signaling molecule in many cancers. Studies have shown that oclacitinib binds to the phosphate group on the ATP-binding site of the enzyme, preventing it from binding to its receptor. Oclacitinib has been shown to be safe and well tolerated for long-term use in diabetic patients. This drug has also been shown to inhibit PDL1 expression and inhibit insulin-like growth factor 1 (IGF1).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
453.51 g/mol
Formula:
C19H27N5O6S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
